EXHIBIT 1

       GIVEN IMAGING ANNOUNCES RESULTS OF 2003 ANNUAL SHAREHOLDERS MEETING

                  Shareholders Approve All Proposed Resolutions

Yoqneam, Israel, June 19, 2003 -- Given Imaging Ltd. (NASDAQ: GIVN) announced
today the approval of all four of the resolutions proposed at the company's 2003
Annual Shareholders Meeting held on June 18, 2003, in Yoqneam, Israel. Over 90%
of the all outstanding shares of the company were voted.

The four proposals were (1) to re-elect all eight of the current directors of
the company, (2) to re-appoint Somekh Chaikin, a member of KPMG International,
as the company's independent auditors for the fiscal year 2003, (3) to approve
the 2003 Stock Option Plan, and reserve 1,500,000 ordinary shares for issuance
under the plan, and (4) to approve certain compensation for the directors of the
Company pursuant to the requirements of Israeli law.

The board of directors thanks the shareholders for their participation and
continued support.

About Given Imaging

Given Imaging develops, produces and markets the Given(R) Diagnostic System
featuring the M2A(R) Capsule Endoscope, the only non-invasive method for direct
visualization of the entire small intestine. The system uses a disposable
miniature video camera contained in a capsule which is ingested by the patient.
The M2A capsule passes naturally through the digestive tract, transmitting high
quality color images, without interfering with the patient's normal activities.
The system received clearance from the FDA in August 2001 and received
permission to affix the CE mark in May 2001. Distribution channels for the
system have been established in more than 50 countries worldwide. The M2A has
been utilized to diagnose a range of diseases of the small intestine including
Crohn's Disease, Celiac disease and other malabsorption disorders, benign and
malignant tumors of the small intestine, vascular disorders, medication related
small bowel injury, as well as a range of pediatric small bowel disorders. For
more information, visit http://www.givenimaging.com.

                                      # # #

This press release contains forward-looking statements about Given Imaging,
including projections about our business, our future revenues, and our future
profitability, within the meaning of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934. For example, statements
in the future tense, words such as "anticipates," "estimates," "expects,"
"intends," "plans," "believes," and words and terms of similar substance used in
connection with any discussion of future operating or financial performance
identify such forward-looking statements. Those forward-looking statements are
not guarantees of future performance and actual results could differ materially
from our current expectations as a result of numerous factors, including but not
limited to the following: changes in regulatory
<PAGE>

environment, our success in implementing our sales, marketing and manufacturing
plan, protection and validity of patents and other intellectual property rights,
the impact of currency exchange rates, the effect of competition by other
companies, the outcome of future litigation, the reimbursement policies for our
product from healthcare payors, quarterly variations in operating results, the
possibility of armed conflict or civil or military unrest in Israel and other
risks disclosed in our filings with the U.S. Securities Exchange Commission.

                                      # # #